Vantage Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Vantage Wealth's AMGN Position: Q4 2025 in Review
Vantage Wealth reduced its Amgen (AMGN) stake by 2.6% in Q4 2025, selling an estimated $539K and leaving 63,729 shares worth $20.9M. The position accounts for 4.51% of the portfolio, ranked #9.
Vantage Wealth first reported a position in AMGN in Q1 2020 and has held it in 24 quarters since. The position peaked at $21.7M in Q4 2023. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Vantage Wealth held 63,729 shares of Amgen worth $20.9M as of Q4 2025.
- Vantage Wealth sold 1,700 Amgen shares in Q4 2025, an estimated $539K.
- Amgen made up 4.51% of Vantage Wealth's portfolio in Q4 2025, its #9 holding.
- Vantage Wealth first reported a position in Amgen in Q1 2020 and has held it in 24 quarters since.
- Vantage Wealth's Amgen position peaked at $21.7M in Q4 2023.
- 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Vantage Wealth's 13F filing for Q4 2025, filed 14 Jan 2026.